Poly Medicure Share Price
Poly Medicure Ltd.
Today’s Low
Today’s High
52W Low
52W High
Open Price
Prev. Close
Volume
Value
Market Cap |
P/E Ratio |
P/B Ratio |
Industry P/E |
---|---|---|---|
Rs. 9310.59 Cr |
62.31 |
8.46 |
341.94 |
ROE |
EPS (TTM) |
Dividend Yield |
Book Value |
---|---|---|---|
14.40 % |
15.23 |
0.26 % |
122.47 |
All you have to do to buy Poly Medicure Ltd. share is download Nuuu app, create a demat account, and get your KYC documents verified online.
Yes you can buy Poly Medicure Ltd. shares, all you need is to have a verified demat account with Nuuu. And enjoy benefits like free brokerage credits and more.
As of 29 Mar`23 the Market Cap of Poly Medicure Ltd. is 9310.59.
As of 29 Mar`23 the PE is 62.31 and PB is 8.46.
The revenue zoomed 24.56% to Rs. 2639.87 millions for the quarter ended September 2022 as compared to Rs. 2119.32 millions during the corresponding quarter last year.A humble growth in net profit of 21.10% reported in the quarter ended September 2022 to Rs. 452.21 millions from Rs. 373.43 millions.Operating Profit saw a handsome growth to 749.87 millions from 627.48 millions in the quarter ended September 2022.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
Sales | 2639.87 | 2119.32 | 24.56 | 5029.95 | 4149.04 | 21.23 | 8793.58 | 7473.82 | 17.66 |
Other Income | 87.07 | 122.92 | -29.17 | 132.84 | 225.24 | -41.02 | 387.29 | 192.88 | 100.79 |
PBIDT | 749.87 | 627.48 | 19.51 | 1277.67 | 1269.54 | 0.64 | 2508.61 | 2276.10 | 10.22 |
Interest | 2.90 | 0.31 | 835.48 | 13.59 | 30.53 | -55.49 | 36.07 | 79.12 | -54.41 |
PBDT | 746.97 | 627.17 | 19.10 | 1264.08 | 1239.01 | 2.02 | 2472.54 | 2196.98 | 12.54 |
Depreciation | 137.24 | 131.88 | 4.06 | 273.06 | 257.41 | 6.08 | 525.40 | 463.14 | 13.44 |
PBT | 609.73 | 495.29 | 23.11 | 991.02 | 981.60 | 0.96 | 1947.14 | 1733.84 | 12.30 |
TAX | 157.52 | 121.86 | 29.26 | 250.81 | 247.86 | 1.19 | 486.98 | 438.72 | 11.00 |
Deferred Tax | 13.84 | 10.72 | 29.10 | 10.47 | 19.12 | -45.24 | 26.60 | -0.83 | -3304.82 |
PAT | 452.21 | 373.43 | 21.10 | 740.21 | 733.74 | 0.88 | 1460.16 | 1295.12 | 12.74 |
Equity | 479.59 | 479.40 | 0.04 | 479.59 | 479.40 | 0.04 | 479.50 | 479.40 | 0.02 |
PBIDTM(%) | 28.41 | 29.61 | -4.06 | 25.40 | 30.60 | -16.99 | 28.53 | 30.45 | -6.33 |
The December 2022 quarter revenue stood at Rs. 2717.39 millions, up 23.51% as compared to Rs. 2200.12 millions during the corresponding quarter last year.A comparatively good net profit growth of 38.98% to Rs. 475.40 millions was reported for the quarter ended December 2022 compared to Rs. 342.07 millions of previous same quarter.Operating profit surged to 826.67 millions from the corresponding previous quarter of 580.57 millions.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
Sales | 2717.39 | 2200.12 | 23.51 | 7747.34 | 6349.16 | 22.02 | 8793.58 | 7473.82 | 17.66 |
Other Income | 143.48 | 72.04 | 99.17 | 276.32 | 297.28 | -7.05 | 387.29 | 192.88 | 100.79 |
PBIDT | 826.67 | 580.57 | 42.39 | 2104.34 | 1850.11 | 13.74 | 2508.61 | 2276.10 | 10.22 |
Interest | 47.27 | -7.50 | -730.27 | 60.86 | 23.03 | 164.26 | 36.07 | 79.12 | -54.41 |
PBDT | 779.40 | 588.07 | 32.54 | 2043.48 | 1827.08 | 11.84 | 2472.54 | 2196.98 | 12.54 |
Depreciation | 136.18 | 132.72 | 2.61 | 409.24 | 390.13 | 4.90 | 525.40 | 463.14 | 13.44 |
PBT | 643.22 | 455.35 | 41.26 | 1634.24 | 1436.95 | 13.73 | 1947.14 | 1733.84 | 12.30 |
TAX | 167.82 | 113.28 | 48.15 | 418.63 | 361.14 | 15.92 | 486.98 | 438.72 | 11.00 |
Deferred Tax | 0.44 | 3.63 | -87.88 | 10.91 | 22.75 | -52.04 | 26.60 | -0.83 | -3304.82 |
PAT | 475.40 | 342.07 | 38.98 | 1215.61 | 1075.81 | 12.99 | 1460.16 | 1295.12 | 12.74 |
Equity | 479.59 | 479.50 | 0.02 | 479.59 | 479.50 | 0.02 | 479.50 | 479.40 | 0.02 |
PBIDTM(%) | 30.42 | 26.39 | 15.28 | 27.16 | 29.14 | -6.79 | 28.53 | 30.45 | -6.33 |
The December 2022 quarter revenue stood at Rs. 2717.39 millions, up 23.51% as compared to Rs. 2200.12 millions during the corresponding quarter last year.A comparatively good net profit growth of 38.98% to Rs. 475.40 millions was reported for the quarter ended December 2022 compared to Rs. 342.07 millions of previous same quarter.Operating profit surged to 826.67 millions from the corresponding previous quarter of 580.57 millions.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
Sales | 2717.39 | 2200.12 | 23.51 | 7747.34 | 6349.16 | 22.02 | 8793.58 | 7473.82 | 17.66 |
Other Income | 143.48 | 72.04 | 99.17 | 276.32 | 297.28 | -7.05 | 387.29 | 192.88 | 100.79 |
PBIDT | 826.67 | 580.57 | 42.39 | 2104.34 | 1850.11 | 13.74 | 2508.61 | 2276.10 | 10.22 |
Interest | 47.27 | -7.50 | -730.27 | 60.86 | 23.03 | 164.26 | 36.07 | 79.12 | -54.41 |
PBDT | 779.40 | 588.07 | 32.54 | 2043.48 | 1827.08 | 11.84 | 2472.54 | 2196.98 | 12.54 |
Depreciation | 136.18 | 132.72 | 2.61 | 409.24 | 390.13 | 4.90 | 525.40 | 463.14 | 13.44 |
PBT | 643.22 | 455.35 | 41.26 | 1634.24 | 1436.95 | 13.73 | 1947.14 | 1733.84 | 12.30 |
TAX | 167.82 | 113.28 | 48.15 | 418.63 | 361.14 | 15.92 | 486.98 | 438.72 | 11.00 |
Deferred Tax | 0.44 | 3.63 | -87.88 | 10.91 | 22.75 | -52.04 | 26.60 | -0.83 | -3304.82 |
PAT | 475.40 | 342.07 | 38.98 | 1215.61 | 1075.81 | 12.99 | 1460.16 | 1295.12 | 12.74 |
Equity | 479.59 | 479.50 | 0.02 | 479.59 | 479.50 | 0.02 | 479.50 | 479.40 | 0.02 |
PBIDTM(%) | 30.42 | 26.39 | 15.28 | 27.16 | 29.14 | -6.79 | 28.53 | 30.45 | -6.33 |
Quarterly Results
Quarterly Results
Rs.2.5000 per share(50%)Final Dividend
Final Dividend & Audited Results
Quarterly Results
Quarterly Results
Rs.2.5000 per share(50%)Dividend
Quarterly Results
Dividend & Audited Results Iinter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2021. b) To consider recommendation of Final Dividend, if any, on the Equity Shares for the financial year ended on 31st March, 2021. c) To transact any other matter which the Board may deem fit.
Quarterly Results
inter alia, to consider and approve the proposal of fund raising by way of debts, equity shares, convertible/non-convertible securities or other equity linked securities on preferential basis/private placement basis, for such amount and on such terms and conditions as may be decided by the Board of Directors at the aforesaid meeting.